Evotec SE (EVO) Non-cash Items (2021 - 2026)
Evotec SE's (EVO) quarterly Non-cash Items came in at $54474.8 in Q1 2026, up 57.07% year-on-year from $34681.7 in Q1 2025, and down 58.55% quarter-over-quarter from $131413.5 in Q3 2025.
Evotec SE (EVO) Non-cash Items (2021 - 2026) Analysis & Trends
Evotec SE has disclosed Non-cash Items across 6 years of filings, most recently posting $54474.8 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evotec SE | 570.60 Mn | 570.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,474.80 |
| Mar 31, 2026 | 54,474.80 |
| Sep 30, 2025 | 131,413.48 |
| Sep 30, 2025 | 131,413.48 |
| Jun 30, 2025 | 46,052.65 |
| Jun 30, 2025 | 46,052.65 |
| Mar 31, 2025 | 34,681.68 |
| Mar 31, 2025 | 34,681.68 |
| Sep 30, 2024 | 135,072.21 |
| Sep 30, 2024 | 135,072.21 |
| Jun 30, 2024 | 98,284.30 |
| Jun 30, 2024 | 98,284.30 |
| Mar 31, 2024 | 35,436.03 |
| Mar 31, 2024 | 35,436.03 |
| Sep 30, 2023 | 118,388.57 |
| Sep 30, 2023 | 118,388.57 |
| Jun 30, 2023 | 65,003.34 |
| Jun 30, 2023 | 65,003.34 |
| Mar 31, 2023 | 52,425.23 |
| Mar 31, 2023 | 52,425.23 |